Literature DB >> 1186296

Benign breast lesions and subsequent breast carcinoma in Rochester, Minnesota.

P K Donnelly, K W Baker, J A Carney, W M O'Fallon.   

Abstract

Case histories of 444 female patients (Rochester residents) with benign breast disease pathologically diagnosed between 1935 and 1949 were studied prospectively for the development of breast cancer. After exclusion of unsuitable cases, 370 remained for review of pathologic diagnoses and statistical analysis. Breast cancer developed in 14 (3.8%) within a median period of 13.5 years after the diagnosis of benign breast disease. Most of these malignancies occurred within 10 years after the original diagnosis. Patients in whom the original diagnosis was chronic cystic mastitis developed breast cancer 2.9 times more frequently than expected. Breast cancer developed 10 times as often as expected in those patients of ages 40 to 49 at the time of diagnosis of breast malignancy. This evidence shows that a more intensive follow-up of patients with confirmed chronic cystic breast disease is justified, especially among those of ages 30 to 49 years.

Entities:  

Mesh:

Year:  1975        PMID: 1186296

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  8 in total

Review 1.  Epidemiology and endocrinology of benign breast disease.

Authors:  D Y Wang; I S Fentiman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

2.  Corpus luteum dysfunction and the epidemiology of breast cancer: a reconsideration.

Authors:  B M Sherman; R B Wallace; S G Korenman
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

Review 3.  Progress in understanding breast cancer: epidemiological and biological interactions.

Authors:  P Boyle; R Leake
Journal:  Breast Cancer Res Treat       Date:  1988-05       Impact factor: 4.872

4.  Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population.

Authors:  Maria J Worsham; Judith Abrams; Usha Raju; Alissa Kapke; Mei Lu; Jingfang Cheng; Donna Mott; Sandra R Wolman
Journal:  Breast J       Date:  2007 Mar-Apr       Impact factor: 2.431

5.  Risk factors for benign breast disease: a 30-year cohort study.

Authors:  T G Hislop; J M Elwood
Journal:  Can Med Assoc J       Date:  1981-02-01       Impact factor: 8.262

Review 6.  Anatomic indicators (histologic and cytologic) of increased breast cancer risk.

Authors:  D L Page; W D Dupont
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

7.  A clinicopathologic correlation of mammographic parenchymal patterns and associated risk factors for human mammary carcinoma.

Authors:  K I Bland; J G Kuhns; J B Buchanan; P A Dwyer; L F Heuser; C A O'Connor; L A Gray; H C Polk
Journal:  Ann Surg       Date:  1982-05       Impact factor: 12.969

8.  A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.

Authors:  R O'Connor; J K MacFarlane; D Murray; D M Thomson
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.